EUVIMEDEUVIMED entdecken
Crossref

Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs

Yu A Nikolaev, T N Mukhina, V D Potapov, B B Kuznetsov, G I El'-Registan, V V Firstova, I G Shemyakin, O Yu Manzenyuk

Bulletin of Experimental Biology and Medicine · 2024

DOI: 10.1007/s10517-024-06048-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Experimental Biology and Medicine, 2024. Verfasst von Yu A Nikolaev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Federal Research Centre "Fundamentals of Biotechnology", Russian Academy of Sciences, Moscow, Russia. Hauptthemen laut MEDLINE: Hexylresorcinol, Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We studied the possibility of using 4-hexylresorcinol to increase the efficiency of anti-mycobacterial chemotherapy. In an in vitro experiment, 4-hexylresorcinol increased the efficiency of rifampicin, kanamycin, and isoniazid against Mycobacterium smegmatis by 3-5 times. Experiments in sanitation of BALB/c mice infected with M. smegmatis showed the best efficacy of the isoniazid and 4-hexylresorcinol combination in comparison with isoniazid monotherapy. The growth-inhibiting activity of the combination of antibiotic rifabutin with 4-hexylresorcinol was shown on 6 strains of M. tuberculosis. A 2-fold decrease in the minimum inhibitory concentration of this antibiotic in the presence of half-minimum inhibitory concentration of 4-hexylresorcinol was demonstrated for monoresistant strain M. tuberculosis 5360/42Hr. On the mouse model of experimental tuberculosis caused by M. tuberculosis H37Rv, a 5-fold decrease in lung contamination and more rapid complete cure were achieved in animals treated with the combination of rifabutin and 4-hexylresorcinol in comparison with rifabutin monotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HexylresorcinolMycobacterium tuberculosisTuberculosisAnimalsMiceAntitubercular AgentsIsoniazidRifabutinMicrobial Sensitivity TestsAdjuvants, Immunologic

Stichwörter der Autor:innen

Mycobacterium smegmatisMycobacterium tuberculosisadjuvant 4-hexylresorcinolisoniazidrifabutin

Substanzen

Antitubercular AgentsIsoniazidHexylresorcinolRifabutinAdjuvants, Immunologic

Autor:innen und Institutionen

  • Federal Research Centre "Fundamentals of Biotechnology", Russian Academy of Sciences, Moscow, Russia.
  • State Research Center for Applied Microbiology and Biotechnology, Federal Service of Consumer Right Surveillance and Human Welfare, Obolensk, Moscow Region, Russia.
  • State Research Center for Applied Microbiology and Biotechnology, Federal Service of Consumer Right Surveillance and Human Welfare, Obolensk, Moscow Region, Russia. manzenyuk@obolensk.org.

Zitieren

APA

Nikolaev, Y. A., Mukhina, T. N., Potapov, V. D., Kuznetsov, B. B., El'-Registan, G. I., Firstova, V. V., Shemyakin, I. G., & Manzenyuk, O. Y. (2024). Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06048-5

Vancouver

Nikolaev YA, Mukhina TN, Potapov VD, Kuznetsov BB, El'-Registan GI, Firstova VV, et al. Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs. Bulletin of Experimental Biology and Medicine. 2024. doi:10.1007/s10517-024-06048-5

BibTeX
@article{Nikolaev2024,
  author = {Nikolaev, Yu A and Mukhina, T N and Potapov, V D and Kuznetsov, B B and El'-Registan, G I and Firstova, V V and Shemyakin, I G and Manzenyuk, O Yu},
  title = {Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs},
  journal = {Bulletin of Experimental Biology and Medicine},
  year = {2024},
  doi = {10.1007/s10517-024-06048-5}
}
Kostenlos starten →